(Q39834604)

15 September 2017

title

Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells (English)

1 reference

15 September 2017

3

1 reference

15 September 2017

7

Jürgen Schölmerich

0 references

author name string

Hella Wobser

1

1 reference

15 September 2017

Christoph Dorn

2

1 reference

15 September 2017

Thomas Amann

4

1 reference

15 September 2017

Cornelius Bollheimer

5

1 reference

15 September 2017

Roland Büttner

6

1 reference

15 September 2017

Claus Hellerbrand

8

1 reference

15 September 2017

publication date

1 August 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

19

1 reference

15 September 2017

issue

8

1 reference

15 September 2017

page(s)

996-1005

1 reference

https://scigraph.springernature.com/pub.10.1038/cr.2009.73

15 September 2017

exact match

0 references

cites work

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

The natural history of nonalcoholic fatty liver: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Mitochondrial abnormalities in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Turnover and splanchnic metabolism of free fatty acids and ketones in insulin-dependent diabetics at rest and in response to exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Mechanisms of disease: Mechanisms of hepatic fibrosis and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Intracellular pathways of protein synthesis and secretion in the hepatocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Increases in serum unbound free fatty acid levels following coronary angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Immortal activated human hepatic stellate cells generated by ectopic telomerase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Conditional tetracycline-regulated expression of TGF-β1 in liver of transgenic mice leads to reversible intermediary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Growth arrest and decrease of alpha-SMA and type I collagen expression by palmitic acid in the rat hepatic stellate cell line PAV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Reduced expression of CYLD in human colon and hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -γ and mediates T cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Free fatty acid-induced inhibition of glucose and insulin-like growth factor I-induced deoxyribonucleic acid synthesis in the pancreatic beta-cell line INS-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

7 January 2021

Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

7 January 2021

https://api.crossref.org/works/10.1038%2FCR.2009.73

1 reference

7 January 2021

Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

7 January 2021

The role of focal adhesion kinase-phosphatidylinositol 3-kinase-akt signaling in hepatic stellate cell proliferation and type I collagen expression

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

7 January 2021

Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

7 January 2021

Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

7 January 2021

The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

7 January 2021

Saturated fatty acids induce insulin resistance in podocytes through inhibition of IRS1 via activation of both IKKβ and mTORC1

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

7 January 2021

Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia.

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.73

7 January 2021

Identifiers

DOI

10.1038/CR.2009.73

1 reference

15 September 2017

1 reference